Effect of a dihydrobenzofuran derivative on lipid hydroperoxide-induced rabbit corneal neovascularization

Journal of Pharmacological Sciences

Volumn 103, Issue 2, 2007, Pages 234-240

  Ogura, Hirotsugu ^a   Nakanishi Ueda, Takako ^a   Ueda, Toshihiko ^a   Iwai, Shinichi ^a   Uchida, Seiichi ^b   Saito, Yuta ^a   Taguchi, Yoko ^a   Yasuhara, Hajime ^a   Armstrong, Donald ^a   Oguchi, Katsuji ^a   Koide, Ryohei ^a  

^a SHOWA UNIVERSITY   (Japan)

^b NIPPON SODA CO LTD   (Japan)

Author keywords

Dihydrobenzofuran derivative; Lipid hydroperoxide; Matrix metalloproteinase (MMP); Neovascularization; Vascular endothelial growth factor (VEGF)

Indexed keywords

A 3922; DIHYDROBENZOFURAN DERIVATIVE; GELATIN; GELATINASE B; LINOLEIC ACID HYDROPEROXIDE; LIPID HYDROPEROXIDE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA LIMBUS; CORNEA NEOVASCULARIZATION; CORNEA STROMA; ENZYME ACTIVITY; EYE PHOTOGRAPHY; IMMUNOASSAY; MALE; NONHUMAN; SURGICAL MICROSCOPE; ZYMOGRAPHY;

EID: 33847147233     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0061301     Document Type: Article

References (37)

1. Giuseppe M, Campo F, Squadrito M, Ioculano A, Avenoso B, Zingarelli S, et al. IRFI-016, a new radical scavenger, limits ischemic damage following coronary artery occlusion in rats. Res Commun Chem Pathol Pharmacol. 1992;76:287-303.
2. Calapai G, Squadrito F, Rizzo A, Crisafulli C, Campo GM, Marciano MC, et al. A new antioxidant drug limits brain damage induced by transient cerebral ischaemia. Drug Exp Clin Res. 1993;19:159-164.
3. Bindoli A, Rigobello MP, Musacchio E, Scuri R, Rizzoli V, Galzigna L. Protective action of a new benzofuran derivative on lipid peroxidation and sulphydryl groups oxidation. Pharmacol Res. 1991;24:369-375.
4. Murakami M, Fukatsu K, Ohkawa S, Kasahara F, Sugawara T. ESR study on the antioxidant activity of TAK-218 in biological model membranes. Chem Pharm Bull (Tokyo). 2000;48:784-792.
5. Sandra A, Dietrich P, Jutta B, Slavka B, Stefaan VD, Guy L, et al. Antiangiogenic activity of synthetic dihydrobenzofuran lingnans. J Nat Prod. 2002;65:718-720.
6. Nakanishi-Ueda T, Shimada S, Satoh K, Ueda T, Kamekawa M, Kosuge S, et al. Effect of new quinolones on blue light induced lipid peroxidation in porcine retinal homogenate. In: 5th Inter Symp Ocul Pharmacol Therap. International Proceedings. Bologna: Medimonds; 2004. p. 143-148.
7. Ohia SE, Opere CA, Leday AM. Pharmacological consequences of oxidative stress in ocular tissues. Mutat Res. 2005;579:22-36.
8. Osawa T, Kato Y. Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia. Ann N Y Acad Sci. 2005;1043:440-451.
9. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2000;45:115-134.
10. Dani C, Cecchi A, Bertini G. Role of oxidative stress as physiopathologic factor in the preterm infant. Minerva Pediatr. 2004;56:381-394.
11. Armstrong D, Abdella N, Salman A, Miller N, Abdel-Rahman E, Bojancyzk M. Relationship of lipid peroxides to diabetic complications: comparison with conventional laboratory tests. J Diab Compl. 1992;6:116-122.
12. Alder VA, Su EN, Yu DY, Cringle SJ, Yu PK. Diabetic retinopathy: early functional changes. Clin Exp Pharmacol Physiol. 1997;24:785-788.
13. Tanaka Y. Peroxidative reactions in the vitreous as related to diabetic retinopathy. J Jpn Ophthalmol Soc. 1998;102:576-582.
14. Verdejo C, Marco P, Renau-Piqueras J, Pinazo-Duran MD. Lipid peroxidation in proliferative vitreoretinopathies. Eye. 1999;13:183-188.
15. Spaide RF, Ho-Spaide WC, Browne WR, Armstrong D. Characterization of peroxidized lipids in Bruch's membrane. Retina. 1999;19:141-147.
16. Tamai K, Matsubara A, Tomida K, Matsuda Y, Morita H, Armstrong D, et al. Lipid hydroperxide stimulates leukocyte-endothelium interaction in the retinal microcirculation. Exp Eye Res. 2002;75:69-75.
17. Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transcduction. Free Radic Biol Med. 1997;22:269-285.
18. Schreck R, Riber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 1991;10:2247-2258.
19. Yamada Y, Nakanishi-Ueda T, Yasuda M, Armstrong D, Yamamoto Y, Yamamoto T, et al. Angiogenic effect of lipid hydroperoxide on bovine aortic endothelial cells. J Clin Biochem Nutr. 1998;25:121-130.
20. Nishimura E, Fukuda S, Nakanishi-Ueda T, Ueda T, Higa A, Armstrong D, et al. Upregulation of vascular endothelial growth factor in cultured rabbit corneal cells during lipid hydroperoxide oxidative stress. Showa Univ J Med Sci. 2001;13:35-41.
21. Ueda T, Ueda T, Fukuda S, Browne R, Jenis E, Spengler R, et al. Lipid hydroperoxide-induced tumor necrosis factor (TNF)-α, vascular endothelial growth factor and neovascularization in the rabbit cornea: effect of TNF inhibition. Angiogenesis. 1997;1:174-184.
22. Nakanishi-Ueda T, Ueda T. [Lipid peroxide-induced corneal neovascularization model.] Folia Pharmacol Jpn (Nippon Yakurigaku Zasshi). 2006;128:33-36. (in Japanese)
23. Higa A, Nakanishi-Ueda T, Arai Y, Tsuchiya T, Ueda T, Fukuda S, et al. Lipid hydroperoxide induced corneal neovascularization in hyperglycemic rabbits. Curr Eye Res. 2002;25:49-53.
24. Tsuchiya T, Nakanishi-Ueda T, Higa A, Fukuda S, Ueda T, Minami M, et al. Effect of vitamin E on lipid hydroperoxide-induced corneal neovascularization. J Eye. 2003;20:379-383.
25. Armstrong D, Browne R. Synthesis of lipid and cholesterol hydroperoxide standards. Methods Mol Biol. 1998;108:139-145.
26. Lowry O, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265-275.
27. Kernacki KA, Fridman R, Hazlett LD, Lande MA, Berk RS. In vivo characterization of host and bacterial protease expression during Pseudomonas aeruginosa corneal infections in naive and immunized mice. Curr Eye Res. 1997;16:289-297.
28. Iwai S, Aljada A, Higa A, Nakanishi-Ueda T, Fukuda S, Kamegawa M, et al. Activation of AP-1 and Increased synthesis of MMP-9 in the rabbit retina induced by lipid hydroperoxide. Curr Eye Res. 2006;31:337-346.
29. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992;267:10931-10934.
30. Girotti AW. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res. 1998;39:1529-1542.
31. Armstrong D, Ueda T, Ueda Ta, Hiramitsu T, Stockton R, Brown R, et al. Dose dependent mechanisms of lipid hydroperoxide induced retinal pathology. In: Yagi K, editor. Pathophysiology of lipid peroxide and related free radicals. Tokyo: Japan Socientific Societies Press/Basel: Karger, AG; 1997. p. 57-76.
32. Armstrong D, Ueda T, Ueda Ta, Aljada A, Browne R, Fukuda S, et al. Lipid hydroperoxide stimulates retinal neovascularization in rabbit retina through expression of tumor necrosis factoralpha, vascular endothelial growth factor and platelet-derived growth factor. Angiogenesis. 1998;2:93-104.
33. Klagsbrun M, D'Amore PA. Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev. 1996;7:259-270.
34. Rundhaug JE. Matrix metalloproteinases and angiogenesis. J Cell Mol Med. 2005;9:267-285.
35. Iwai S, Nakanishi-Ueda T, Ueda T, Kamiya Y, Nara K, Yura A, et al. Lipid hydroperoxide induced mRNA of MMPs and TIMPs in rabbit retina. J Pharmacol Sci. 2004;94:122.
36. Miyazawa T, Tsuzuki T, Nakagawa K, Igarashi M. Antiangigenic potency of vitamin E. Ann N Y Acad Sci. 2004;1031:401-404.
37. Malafa MP, Fokum FD, Smith L, Louis A. Inhibition of angiogenesis and promotion of melanoma dormancy by vitamin E succinate. Ann Surg Oncol. 2002;9:1023-1032.